{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:32:11Z","timestamp":1794025931244,"version":"4.8.0"},"reference-count":76,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2011,1,30]],"date-time":"2011-01-30T00:00:00Z","timestamp":1296345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2011,4]]},"abstract":"<jats:p>Inherited mutations in the tumor suppressor genes <jats:italic>BRCA1<\/jats:italic> and <jats:italic>BRCA2<\/jats:italic> cause increased risk of developing various cancers, especially breast and ovarian cancers. Tumors that develop in patients with inherited <jats:italic>BRCA1\/2<\/jats:italic> mutations are generally believed to be BRCA1\/2\u2010deficient. Cancer cells with BRCA1\/2 deficiency are defective in DNA repair by homologous recombination and sensitive to interstrand DNA crosslinking agents, such as cisplatin and carboplatin, and poly(ADP\u2010ribose) polymerase inhibitors. Therefore, these agents are logical choices for the treatment for BRCA1\/2\u2010deficient tumors and have shown to be clinically effective. However, <jats:italic>BRCA1\/2<\/jats:italic>\u2010mutated tumors often develop resistance to these drugs. Restoration of BRCA1\/2 functions due to secondary <jats:italic>BRCA1\/2<\/jats:italic> mutations has been recognized as a mechanism of acquired resistance to cisplatin and poly(ADP\u2010ribose) polymerase inhibitors in <jats:italic>BRCA1\/2<\/jats:italic>\u2010mutated cancer cells. This indicates that even disease\u2010causing inherited mutations of tumor suppressor genes can be genetically reverted in cancer cells, if the genetic reversion is advantageous for the cells\u2019 survival. In this review, we will discuss this drug resistance mechanism. (<jats:italic>Cancer Sci<\/jats:italic> 2011; 102: 663\u2013669)<\/jats:p>","DOI":"10.1111\/j.1349-7006.2010.01840.x","type":"journal-article","created":{"date-parts":[[2010,12,23]],"date-time":"2010-12-23T19:43:47Z","timestamp":1293133427000},"page":"663-669","source":"Crossref","is-referenced-by-count":123,"title":["Secondary mutations of <i>BRCA1\/2<\/i> and drug resistance"],"prefix":"10.1111","volume":"102","author":[{"given":"Kiranjit K.","family":"Dhillon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Swisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyasu","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,1,30]]},"reference":[{"key":"e_1_2_14_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1123"},{"key":"e_1_2_14_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2006.09.006"},{"key":"e_1_2_14_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature06633"},{"key":"e_1_2_14_5_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-0088"},{"key":"e_1_2_14_6_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-1178"},{"key":"e_1_2_14_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature06548"},{"key":"e_1_2_14_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2010.06.001"},{"key":"e_1_2_14_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2006.048173"},{"key":"e_1_2_14_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.18.1358"},{"key":"e_1_2_14_11_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1088759"},{"key":"e_1_2_14_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.1066"},{"key":"e_1_2_14_13_2","first-page":"6069","article-title":"Loss of heterozygosity in familial tumors from three BRCA1\u2010linked kindreds","volume":"54","author":"Neuhausen SL","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_14_14_2","first-page":"1673","article-title":"Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12\u201013","volume":"10","author":"Collins N","year":"1995","journal-title":"Oncogene"},{"key":"e_1_2_14_15_2","first-page":"4830","article-title":"Different tumor types from BRCA2 carriers show wild\u2010type chromosome deletions on 13q12\u2010q13","volume":"55","author":"Gudmundsson J","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_14_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.10.015"},{"key":"e_1_2_14_17_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1073834"},{"key":"e_1_2_14_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0809889"},{"key":"e_1_2_14_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2006.043257"},{"key":"e_1_2_14_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(00)80202-6"},{"key":"e_1_2_14_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(01)00174-5"},{"key":"e_1_2_14_22_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.39.25388"},{"key":"e_1_2_14_23_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M710245200"},{"key":"e_1_2_14_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature09399"},{"key":"e_1_2_14_25_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-1012"},{"key":"e_1_2_14_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0b013e3181cf0204"},{"key":"e_1_2_14_27_2","first-page":"3547","article-title":"BRCA2 is required for ionizing radiation\u2010induced assembly of Rad51 complex in vivo","volume":"59","author":"Yuan SS","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_14_28_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C000276200"},{"key":"e_1_2_14_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03443"},{"key":"e_1_2_14_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03445"},{"key":"e_1_2_14_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.21811"},{"key":"e_1_2_14_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.20.21.8283-8289.2000"},{"key":"e_1_2_14_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600993"},{"key":"e_1_2_14_34_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1182372"},{"key":"e_1_2_14_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.17.2260"},{"key":"e_1_2_14_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11310"},{"key":"e_1_2_14_37_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.6905"},{"key":"e_1_2_14_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2812"},{"key":"e_1_2_14_39_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0900212"},{"key":"e_1_2_14_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60893-8"},{"key":"e_1_2_14_41_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.9589"},{"key":"e_1_2_14_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60892-6"},{"key":"e_1_2_14_43_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0806092105"},{"key":"e_1_2_14_44_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.40.10.721"},{"key":"e_1_2_14_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05916.x"},{"key":"e_1_2_14_46_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-07-2638"},{"key":"e_1_2_14_47_2","first-page":"2688","article-title":"Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2","volume":"63","author":"Ikeda H","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_14_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2006.03.001"},{"key":"e_1_2_14_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.13.978"},{"key":"e_1_2_14_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb1245"},{"key":"e_1_2_14_51_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-3416"},{"key":"e_1_2_14_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L"},{"key":"e_1_2_14_53_2","first-page":"6166","article-title":"Characterization and properties of nine human ovarian adenocarcinoma cell lines","volume":"48","author":"Langdon SP","year":"1988","journal-title":"Cancer Res"},{"key":"e_1_2_14_54_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209871"},{"key":"e_1_2_14_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/76950"},{"key":"e_1_2_14_56_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0702969104"},{"key":"e_1_2_14_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/8743"},{"key":"e_1_2_14_58_2","doi-asserted-by":"publisher","DOI":"10.1038\/90108"},{"key":"e_1_2_14_59_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204512"},{"key":"e_1_2_14_60_2","first-page":"6194","article-title":"Loss of Brca2 and p53 synergistically promotes genomic instability and deregulation of T\u2010cell apoptosis","volume":"62","author":"Cheung AM","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_14_61_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng747"},{"key":"e_1_2_14_62_2","first-page":"990","article-title":"Cancer susceptibility of mice with a homozygous deletion in the COOH\u2010terminal domain of the Brca2 gene","volume":"62","author":"McAllister KA","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_14_63_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0702955104"},{"key":"e_1_2_14_64_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2388"},{"key":"e_1_2_14_65_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1984"},{"key":"e_1_2_14_66_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-5480"},{"key":"e_1_2_14_67_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.17.4704"},{"key":"e_1_2_14_68_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0800668"},{"key":"e_1_2_14_69_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.3.1014"},{"key":"e_1_2_14_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2008.08.007"},{"key":"e_1_2_14_71_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1011412107"},{"key":"e_1_2_14_72_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M200748200"},{"key":"e_1_2_14_73_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.1831"},{"key":"e_1_2_14_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.03.012"},{"key":"e_1_2_14_75_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-1015"},{"key":"e_1_2_14_76_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3945"},{"key":"e_1_2_14_77_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-09-0201"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2010.01840.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2010.01840.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T01:58:27Z","timestamp":1697421507000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2010.01840.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,30]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["10.1111\/j.1349-7006.2010.01840.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2010.01840.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,30]]}}}